An immune competent mouse model for the characterization of recombinant measles vaccines

References

• GriffinDE, PanCH, MossWJ. Measles vaccines. Front Biosci2008; 13:1352 - 70; http://dx.doi.org/10.2741/2767; PMID: 17981635
   PubMedGoogle Scholar
• CombredetC, LabrousseV, MolletL, LorinC, DelebecqueF, HurtrelB, McClureH, FeinbergMB, BrahicM, TangyF. A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol2003; 77:11546 - 54; http://dx.doi.org/10.1128/JVI.77.21.11546-11554.2003; PMID: 14557640
   PubMed Web of Science ®Google Scholar
• ZunigaA, LinigerM, MorinTN, MartyRR, WiegandM, IlterO, WeibelS, BilleterMA, KnuchelMC, NaimHY. Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. Hum Vaccin Immunother2013; 9:607 - 13; http://dx.doi.org/10.4161/hv.23242; PMID: 23324616
   PubMed Web of Science ®Google Scholar
• del ValleJR, DevauxP, HodgeG, WegnerNJ, McChesneyMB, CattaneoR. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol2007; 81:10597 - 605; http://dx.doi.org/10.1128/JVI.00923-07; PMID: 17634218
   PubMed Web of Science ®Google Scholar
• BrandlerS, Lucas-HouraniM, MorisA, FrenkielMP, CombredetC, FévrierM, BedouelleH, SchwartzO, DesprèsP, TangyF. Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. PLoS Negl Trop Dis2007; 1:e96; http://dx.doi.org/10.1371/journal.pntd.0000096; PMID: 18160988
   PubMed Web of Science ®Google Scholar
• LorinC, MolletL, DelebecqueF, CombredetC, HurtrelB, CharneauP, BrahicM, TangyF. A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol2004; 78:146 - 57; http://dx.doi.org/10.1128/JVI.78.1.146-157.2004; PMID: 14671096
   PubMed Web of Science ®Google Scholar
• DesprèsP, CombredetC, FrenkielMP, LorinC, BrahicM, TangyF. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis2005; 191:207 - 14; http://dx.doi.org/10.1086/426824; PMID: 15609230
   PubMed Web of Science ®Google Scholar
• WangZ, HangartnerL, CornuTI, MartinLR, ZunigaA, BilleterMA, NaimHY. Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine2001; 19:2329 - 36; http://dx.doi.org/10.1016/S0264-410X(00)00523-5; PMID: 11257357
   PubMed Web of Science ®Google Scholar
• LinigerM, ZunigaA, TaminA, Azzouz-MorinTN, KnuchelM, MartyRR, WiegandM, WeibelS, KelvinD, RotaPA, et al. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine2008; 26:2164 - 74; PMID: 18346823
   PubMed Web of Science ®Google Scholar
• LiS, LockeE, BruderJ, ClarkeD, DoolanDL, HavengaMJ, HillAV, LiljestromP, MonathTP, NaimHY, et al. Viral vectors for malaria vaccine development. Vaccine2007; 25:2567 - 74; http://dx.doi.org/10.1016/j.vaccine.2006.07.035; PMID: 16914237
   PubMed Web of Science ®Google Scholar
• CantarellaG, LinigerM, ZunigaA, SchillerJT, BilleterM, NaimHY, GlueckR. Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma. Vaccine2009; 27:3385 - 90; http://dx.doi.org/10.1016/j.vaccine.2009.01.061; PMID: 19200837
   PubMed Web of Science ®Google Scholar
• BilleterMA, NaimHY, UdemSA. Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses. Curr Top Microbiol Immunol2009; 329:129 - 62; http://dx.doi.org/10.1007/978-3-540-70523-9_7; PMID: 19198565
   PubMed Web of Science ®Google Scholar
• MrkicB, PavlovicJ, RülickeT, VolpeP, BuchholzCJ, HourcadeD, AtkinsonJP, AguzziA, CattaneoR. Measles virus spread and pathogenesis in genetically modified mice. J Virol1998; 72:7420 - 7; PMID: 9696838
   PubMed Web of Science ®Google Scholar
• van BinnendijkRS, van der HeijdenRW, OsterhausAD. Monkeys in measles research. Curr Top Microbiol Immunol1995; 191:135 - 48; http://dx.doi.org/10.1007/978-3-642-78621-1_9; PMID: 7789157
   PubMedGoogle Scholar
• DörigRE, MarcilA, ChopraA, RichardsonCD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell1993; 75:295 - 305; http://dx.doi.org/10.1016/0092-8674(93)80071-L; PMID: 8402913
   PubMed Web of Science ®Google Scholar
• BaccalaR, KonoDH, TheofilopoulosAN. Interferons as pathogenic effectors in autoimmunity. Immunol Rev2005; 204:9 - 26; http://dx.doi.org/10.1111/j.0105-2896.2005.00252.x; PMID: 15790347
   PubMed Web of Science ®Google Scholar
• SadlerAJ, WilliamsBR. Interferon-inducible antiviral effectors. Nat Rev Immunol2008; 8:559 - 68; http://dx.doi.org/10.1038/nri2314; PMID: 18575461
   PubMed Web of Science ®Google Scholar
• Le BonA, ToughDF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol2002; 14:432 - 6; http://dx.doi.org/10.1016/S0952-7915(02)00354-0; PMID: 12088676
   PubMed Web of Science ®Google Scholar
• Havenar-DaughtonC, KolumamGA, Murali-KrishnaK. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol2006; 176:3315 - 9; http://dx.doi.org/10.4049/jimmunol.176.6.3315; PMID: 16517698
   PubMed Web of Science ®Google Scholar
• RallGF, ManchesterM, DanielsLR, CallahanEM, BelmanAR, OldstoneMB. A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A1997; 94:4659 - 63; http://dx.doi.org/10.1073/pnas.94.9.4659; PMID: 9114047
   PubMedGoogle Scholar
• OhnoS, OnoN, SekiF, TakedaM, KuraS, TsuzukiT, YanagiY. Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol2007; 81:1650 - 9; http://dx.doi.org/10.1128/JVI.02134-06; PMID: 17135325
   PubMedGoogle Scholar
• YanagiY, HuHL, SeyaT, YoshikuraH. Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46. Arch Virol1994; 138:39 - 53; http://dx.doi.org/10.1007/BF01310037; PMID: 7980010
   PubMedGoogle Scholar
• KemperC, LeungM, StephensenCB, PinkertCA, LiszewskiMK, CattaneoR, AtkinsonJP. Membrane cofactor protein (MCP; CD46) expression in transgenic mice. Clin Exp Immunol2001; 124:180 - 9; http://dx.doi.org/10.1046/j.1365-2249.2001.01458.x; PMID: 11422193
   PubMed Web of Science ®Google Scholar
• ShingaiM, InoueN, OkunoT, OkabeM, AkazawaT, MiyamotoY, AyataM, HondaK, Kurita-TaniguchiM, MatsumotoM, et al. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. J Immunol2005; 175:3252 - 61; http://dx.doi.org/10.4049/jimmunol.175.5.3252; PMID: 16116216
   PubMedGoogle Scholar
• ManchesterM, EtoDS, ValsamakisA, LitonPB, Fernandez-MuñozR, RotaPA, BelliniWJ, ForthalDN, OldstoneMB. Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol2000; 74:3967 - 74; http://dx.doi.org/10.1128/JVI.74.9.3967-3974.2000; PMID: 10756008
   PubMedGoogle Scholar
• TatsuoH, OnoN, TanakaK, YanagiY. SLAM (CDw150) is a cellular receptor for measles virus. Nature2000; 406:893 - 7; http://dx.doi.org/10.1038/35022579; PMID: 10972291
   PubMed Web of Science ®Google Scholar
• HorvatB, RivaillerP, Varior-KrishnanG, CardosoA, GerlierD, Rabourdin-CombeC. Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol1996; 70:6673 - 81; PMID: 8794303
   PubMed Web of Science ®Google Scholar
• YannoutsosN, IjzermansJN, HarkesC, BonthuisF, ZhouCY, WhiteD, MarquetRL, GrosveldF. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cells1996; 1:409 - 19; http://dx.doi.org/10.1046/j.1365-2443.1996.d01-244.x; PMID: 9135084
   PubMed Web of Science ®Google Scholar
• OldstoneMB, LewickiH, ThomasD, TishonA, DalesS, PattersonJ, ManchesterM, HomannD, NanicheD, HolzA. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell1999; 98:629 - 40; http://dx.doi.org/10.1016/S0092-8674(00)80050-1; PMID: 10490102
   PubMed Web of Science ®Google Scholar
• YanagiY, TakedaM, OhnoS. Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol2006; 87:2767 - 79; http://dx.doi.org/10.1099/vir.0.82221-0; PMID: 16963735
   PubMed Web of Science ®Google Scholar
• OnoN, TatsuoH, TanakaK, MinagawaH, YanagiY. V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol2001; 75:1594 - 600; http://dx.doi.org/10.1128/JVI.75.4.1594-1600.2001; PMID: 11160657
   PubMed Web of Science ®Google Scholar
• VerhaaghS, de JongE, GoudsmitJ, LecollinetS, GillissenG, de VriesM, van LeuvenK, QueI, OuwehandK, MintardjoR, et al. Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors. J Gen Virol2006; 87:255 - 65; http://dx.doi.org/10.1099/vir.0.81293-0; PMID: 16432010
   PubMed Web of Science ®Google Scholar
• NanicheD, Varior-KrishnanG, CervoniF, WildTF, RossiB, Rabourdin-CombeC, GerlierD. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol1993; 67:6025 - 32; PMID: 8371352
   PubMed Web of Science ®Google Scholar
• LinigerM, ZunigaA, MorinTN, CombardiereB, MartyR, WiegandM, IlterO, KnuchelM, NaimHY. Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine2009; 27:3299 - 305; http://dx.doi.org/10.1016/j.vaccine.2009.01.057; PMID: 19200842
   PubMed Web of Science ®Google Scholar
• ZunigaA, WangZ, LinigerM, HangartnerL, CaballeroM, PavlovicJ, WildP, ViretJF, GlueckR, BilleterMA, et al. Attenuated measles virus as a vaccine vector. Vaccine2007; 25:2974 - 83; http://dx.doi.org/10.1016/j.vaccine.2007.01.064; PMID: 17303293
   PubMed Web of Science ®Google Scholar
• MüllerU, SteinhoffU, ReisLF, HemmiS, PavlovicJ, ZinkernagelRM, AguetM. Functional role of type I and type II interferons in antiviral defense. Science1994; 264:1918 - 21; http://dx.doi.org/10.1126/science.8009221; PMID: 8009221
   PubMed Web of Science ®Google Scholar
• ZhangSY, JouanguyE, Sancho-ShimizuV, von BernuthH, YangK, AbelL, PicardC, PuelA, CasanovaJL. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol Rev2007; 220:225 - 36; http://dx.doi.org/10.1111/j.1600-065X.2007.00564.x; PMID: 17979850
   PubMed Web of Science ®Google Scholar
• NossalGJ. Vaccines of the future. Vaccine2011; 29:Suppl 4D111 - 5; http://dx.doi.org/10.1016/j.vaccine.2011.06.089; PMID: 22185835
   PubMedGoogle Scholar
• NomuraLE, EmuB, HohR, HaalandP, DeeksSG, MartinJN, McCuneJM, NixonDF, MaeckerHT. IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells. AIDS Res Ther2006; 3:18; http://dx.doi.org/10.1186/1742-6405-3-18; PMID: 16859558
   PubMedGoogle Scholar
• Combadiere B. Understanding Mechanism of Skin Vaccination and Tailored Immunity to Vaccines. Ninth World Congress on Vaccines, Immunisation and Immunotherapy 2014;abstract PS1-5.
   Google Scholar
• KnuchelMC, MartyRR, MorinTN, IlterO, ZunigaA, NaimHY. Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector. Hum Vaccin Immunother2013; 9:599 - 606; http://dx.doi.org/10.4161/hv.23241; PMID: 23324399
   PubMed Web of Science ®Google Scholar
• RadeckeF, SpielhoferP, SchneiderH, KaelinK, HuberM, DötschC, ChristiansenG, BilleterMA. Rescue of measles viruses from cloned DNA. EMBO J1995; 14:5773 - 84; PMID: 8846771
   PubMed Web of Science ®Google Scholar
• SchadeckEB, PartidosCD, FooksAR, ObeidOE, WilkinsonGW, StephensonJR, StewardMW. CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice. Virus Res1999; 65:75 - 86; http://dx.doi.org/10.1016/S0168-1702(99)00103-3; PMID: 10564754
   PubMed Web of Science ®Google Scholar